Strong growth in non-US markets lifted Strides Pharma Science’s Q4 profit, even as its US business remained largely flat amid a weak flu seasonStrong growth in non-US markets lifted Strides Pharma Science’s Q4 profit, even as its US business remained largely flat amid a weak flu season Home Page [ SOBAN NEWS: International and National ]